Journal
JOURNAL OF PROTEOME RESEARCH
Volume 17, Issue 11, Pages 3730-3739Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jproteome.8b00411
Keywords
glycoprotein; inflammation; rheumatoid arthritis (RA); proton nuclear magnetic resonance (H-1 NMR)
Categories
Funding
- Generalitat de Catalunya Industrial Ph.D. plan [2014DI0029]
Ask authors/readers for more resources
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease associated with a high index of morbidity and mortality from cardiovascular diseases. We used H-1 NMR to characterize the plasma glycoprotein and lipoprotein profiles of a cohort of patients with RA (n = 210) versus healthy individuals (n = 203) to associate them with the RA disease and its severity. Using H-1 NMR, we developed a line-shape method to characterize the two peaks associated with glycoproteins (GlycA and GlycB) and its derived variables: areas of GlycB (Area GlycB) and GlycA (Area GlycA), shape factors of these two peaks (H/W = height/width), and the distance between them (Distance GlycB GlycA). We also used the advanced lipoprotein test Liposcale (CE) to characterize the lipoprotein subclasses. The standard lipid panel and traditional inflammatory markers such as C-reactive protein, the erythrocyte sedimentation rate, fibrinogen, the rheumatoid factor, anticitrullinated peptide antibodies, and the DAS28 index have also been determined. RA patients presented a significant 10.65% increase in the GlycA associated area compared with the control group (p = 2.21 X 10(-10)). They also presented significantly higher H/W GlycA and GlycB ratios than the control population (H/W GlycB p = 7.88 X 10(-8); H/W GlycA p = 5.61 x 10(-8)). The prediction model that uses the traditional inflammatory variables and the H-1 NMR-derived parameters presented an AUC that was almost 10% higher than the model that only uses the traditional inflammatory variables (from 0.7 to 0.79 AUC). We have demonstrated that GlycA and GlycB variables derived from H-1 NMR, along with classic inflammatory parameters, help to improve the classification of individuals with high RA disease activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available